Previous clinical trials have demonstrated that SCE therapy provided lasting reversal of autoimmune memory T cells evidenced by the up-regulation of the percentages of Naïve T cells and CD4+ TCM and the down-regulation of CD4+ TEM in Caucasian T1D subjects [14]. Here, CD4 is linked to type 1 diabetes mellitus.